RE:RE:RE:RE:RE:RE:RE:Defining BCG-Unresponsive and The Pathway to Clinical TrialsI am also VERY suprised about no news coverage/pub goldn1- it just doesn't add up.... it's almost like the WANT to remain under the radar' (and watch the SP wallow in the toilet) , maybe it's a stragegy to keep the big fish from eating them before they can even show their successful therapy to the world....It would be like having a Ferari in your garage, covered, and you only take it out after dark.... nobody has ever seen this beautiful car..... you wouldnt want to attract attention now would you! . OR maybe it just keeps going back to the tiny PH1 trial population and the medical community just not impressed at all with 6 patients, 2 CR's.....
Forgive my ignorance but don't most PH1 trials ( bladder type spcifically, but many other cancer types as well) have significantly more than 6 patients in a PH1 trial?? Not sure we would be in this position if we had used a greater patient population in PH1??
Welcome civil feedback, again not bashing, just trying to understand how things are unfolding.....
NorCal Tommy